N Williams, S Love, N Gibson… - … Academy of Cerebral …, 2011 - espace.library.uq.edu.au Williams, N., Love, S., Gibson, N. and Blair, E. (2008). Reliability of the Australian Spasticity Assessment Scale. In: P. Baxter, AusACPDM Conference 2008. The Australasian Academy of Cerebral Palsy and Developmental Medicine Broadening the Scope, Brisbane, Qld, Australia, (). 10 – 13 ... Cached - All 3 versions
T Rekand… - … medicine: official journal of the UEMS …, 2011 - ncbi.nlm.nih.gov BACKGROUND: Spasticity is a frequent disabling symptom in patients with multiple sclerosis, which contributes to functional deterioration. OBJECTIVE: To evaluate the long-term effect of intrathecal baclofen therapy in multiple sclerosis-related spasticity and to ... All 2 versions
S Malhotra, AD Pandyan, S Rosewilliam… - Clinical …, 2011 - cre.sagepub.com ...Spasticity and contractures at the wrist after stroke: time course of development and their association with functional recovery of the upper limb. ... Main measures: Spasticity was measured by quantifying muscle activity during passively imposed stretches at two velocities. ... Related articles - All 5 versions
D Westerkam, LL Saunders… - Spinal Cord, 2011 - nature.com Received 6 December 2010; Revised 15 March 2011; Accepted 11 April 2011; Published online 24 May 2011. ... Cross-sectional survey; secondary analysis of existing data by linear regression analysis between spasticity and quality of life. ... To identify the relationship between ... All 3 versions
[PDF] from rancho.orgPW Nance, FJ Huff, A Martinez-Arizala, Z Ayyoub… - Spinal Cord, 2011 - rancho.org Study design: Randomized, double-blind, placebo-controlled, two-period crossover. Objectives: To evaluate the efficacy and safety of arbaclofen placarbil (AP) in patients with spasticity secondary to spinal cord injury (SCI). Setting: United States and Canada. Methods: ... Related articles - View as HTML - All 4 versions